Navigation Links
itLinkz Group, Inc. Changes Name to China YCT International Group, Inc. and Effects Reverse Stock Split
Date:11/26/2007

NEW YORK, Nov. 26 /Xinhua-PRNewswire-FirstCall/ -- itLinkz Group, Inc. ("ILKZ") (the "Company") announced that, effective as of the beginning of trading today, November 26, 2007, the Company has changed its name to "China YCT International Group, Inc." and began trading under its new symbol (OTC Bulletin Board: CYIG). In addition, the Company announced a 1:28 reverse split of its outstanding common shares also effective as of November 26, 2007.

Holders of shares representing a majority of the voting power of the Company have given their written consent to a resolution approving these actions, and an amendment of the Articles of Incorporation to this effect was filed with the Delaware Secretary of State.

China YCT International Group, Inc., through its operating subsidiary, Shandong Spring Pharmaceutical Co., Ltd. ("Shandong Spring"), a corporation organized under the laws of the People's Republic of China, is engaged in the business of the distribution of gingko-based health and beauty products. All of Shandong Spring's business is currently in China.

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks described in statements filed from time to time with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements that may accompany the forward-looking statement
'/>"/>

SOURCE China YCT International Group, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Karen Vigil Named Senior Vice President and Chief Executive Officer, Blue Shield of Californias Individual, Small Group, and Government Business Unit
2. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
3. Air Methods Completes Acquisition of FSS Airholdings, Inc., Parent Company of CJ Systems Aviation Group, Inc.
4. Nyer Medical Group, Inc. Reports EPS of $.02 on Record Revenues of $69.9 Million for Fiscal Year Ended 2007
5. The Mattson Jack Group, Inc. Announces the Release of the New Comorbidity Database(TM)
6. Congress Declares Long Term Care Awareness Week - Long Term Care Group, Inc. Continues Related Work
7. Hanger Orthopedic Group, Inc. Announces Record Revenue of $162.3 Million and 20% Growth in Earnings Per Share for the Quarter Ended September 30, 2007
8. Major EU Funded Nanotube Research Group, DESYGN-IT, Publish in AZoJono - The Open Access Online Nanotech Journal
9. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
10. Medicare Changes Didnt Alter Cancer Care
11. Arbios Announces Management Changes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)... , Amsterdam, 2 December 2008 - Elsevier announce...tters 2008 Supplement on the theme of "Second tri.... Second trimester abortion raises complex issues...providers of service delivery and the sometimes co... This issue of Reproductive Health Matters grew ...
(Date:12/2/2008)... , , WASHINGTON -- A new report from the Institu...ents, duty hours and workloads to decrease the cha...nce the learning environment for these doctors in ...educing residents, work hours from the maximum ave...il for Graduate Medical Education (ACGME) in 2003,...
(Date:12/2/2008)... , , SAN DIEGO, Dec. 2 S...est-growing exercise program for new moms and thei...r in baby care for more than 40 years, has signed ... , The new partnership will strengthen the com...ers and moms. , , "We are thrilled to have ...
(Date:12/2/2008)... Randomized Comparator Study to Evaluate Efficacy... , , WOODCLIFF LAKE, N.J., Dec. 2 /PRNewswi...nounced that it plans to initiate the first clinic...citabine for injection) compared to Vidaza(R) (aza...ntermediate-2 or high-risk myelodysplastic syndrom...
Breaking Medicine News(10 mins):Health News:Elsevier announces the 2008 supplement of Reproductive Health Matters 2Health News:Revised hours and workloads for medical residents needed to prevent 2Health News:Revised hours and workloads for medical residents needed to prevent 3Health News:Stroller Strides(R) Signs Pampers(R) as Premier Sponsor for 2009 2Health News:Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine for injection) and Vidaza(R) (azacitidine) in Patients with Myelodysplastic Syndromes 2Health News:Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine for injection) and Vidaza(R) (azacitidine) in Patients with Myelodysplastic Syndromes 3
... of pharmacology; the number of people taking medi...e recent years. It is however to be noted that com...nsequences, including death. // Several medicatio...can interact or work against each other. Patients ...
...een witness to the death of more than half a milli...e south of Russia.// According to the Federal Con... Jan 25 and Feb 1, almost 350,000 birds have died ...akhkent district, and 76,000 at the Makhachkalinsk...
... effective solutions to major problems. This is es...s now been found that addition of white vinegar to...ively destroy bacterial spores. // Researchers fr... this simple yet significant solution to bacterial...
...tution has warned about the possibility of a hemag... constitution of the much-dreaded avian influenza ...could enable human-human bird flu transmission by ...an receptors. The company has also alerted the WH...
Other Medicine News:Health News:Drug Combinations Could Be Dangerous 2Health News:Genetic Change In The H5N1 Virus Likely: Recombinomics Inc. 2
(Date:12/1/2008)... Dec. 1 GeoVax Labs, Inc...otechnology company developing,human vaccines for...Virus) and,other infectious agents, announced tod...Trials will take place in twelve sites across Nort...n collaboration with The National Institutes of,H...
(Date:11/28/2008)...OLIS, Nov. 28 Eli Lilly ...lemental New Drug Application (sNDA) from,the U.S...R) (duloxetine HCl),for the management of chronic...,the first half of 2009, adding data from a recent...itis pain of the knee. , The decision does ...
(Date:11/25/2008)...awareness can improve recovery , , Audio an...available on the Mayo Clinic News Blog. Please see... , ROCHESTER, Minn., Nov. 25 /PRNewswire-USNew...stroke patients don,t think they,re having a strok...til their condition worsens. The findings appear i...
(Date:11/25/2008)...E, Calif., Nov. 25 Pharm...that the company has completed a Phase 1,clinical...in-class,small-molecule Factor VIIa inhibitor. Th...unteers to evaluate the safety and pharmacologic e...I-27483 resulted in a linear dose,response in the...
Breaking Medicine Technology:GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4Bioheart Founder Howard J Leonhardt Becomes Chairman of the Board of Directors 4022 1Bioheart Founder Howard J Leonhardt Becomes Chairman of the Board of Directors 4022 2Bioheart Founder Howard J Leonhardt Becomes Chairman of the Board of Directors 4022 3Bioheart Founder Howard J Leonhardt Becomes Chairman of the Board of Directors 4022 4NASA satellite measures pollution from east Asia to North America 2532 1NASA satellite measures pollution from east Asia to North America 2532 2NASA satellite measures pollution from east Asia to North America 2532 3Evanston Northwestern Healthcare Researchers Explain Effects of Large Scale Universal MRSA Surveillance Program That Supports Expanded Intervention 1543 1Evanston Northwestern Healthcare Researchers Explain Effects of Large Scale Universal MRSA Surveillance Program That Supports Expanded Intervention 1543 2Evanston Northwestern Healthcare Researchers Explain Effects of Large Scale Universal MRSA Surveillance Program That Supports Expanded Intervention 1543 3Emisphere Technologies Inc Announces 2007 Fourth Quarter and Year End Financial Results 4020 1Emisphere Technologies Inc Announces 2007 Fourth Quarter and Year End Financial Results 4020 2Emisphere Technologies Inc Announces 2007 Fourth Quarter and Year End Financial Results 4020 3Emisphere Technologies Inc Announces 2007 Fourth Quarter and Year End Financial Results 4020 4Emisphere Technologies Inc Announces 2007 Fourth Quarter and Year End Financial Results 4020 5Emisphere Technologies Inc Announces 2007 Fourth Quarter and Year End Financial Results 4020 6Emisphere Technologies Inc Announces 2007 Fourth Quarter and Year End Financial Results 4020 7Emisphere Technologies Inc Announces 2007 Fourth Quarter and Year End Financial Results 4020 8
... Reported Safety & Tolerability Profile,in Sub...CHICAGO, June 25 /PRNewswire-FirstCall/ -- Phase I...of the American Diabetes,Association demonstrated ...dase-4 (DPP-4) in development by Bristol-Myers,Squ...), in,combination with metformin, exhibited a stat...
...Unique Mechanism of Action and Broad Potential for...A, Calif., June 26, 2007 (PRIME NEWSWIRE) -- Avige... innovating therapeutics,for the treatment of neur...pinion on Investigational Drugs has published an a...(ibudilast), a potential,first-in-class, non-opioi...
Other Medicine Technology:Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 2Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 3Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 4Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 5Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 6Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 2Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 3Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 4Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 5
... a compact, stand-alone microprocessor-controlled ...pecimens in 96-well microplates using single- or d...(2.7-for dual-wavelength) and a dynamic reading ra...eet any laboratory or assay requirements. Self-dia...
...rue/Flex technology which has revolutionized the t... unique fluted titanium construct was used in the ... tibia, with its limited blood supply and soft tis...ealing process. The fluted, tapered, non-reamed Tr...
...ac Plus System offers a disposable alternative to ... power efficiently clears bone and cement debris d...ailable for hip and knee applications. Variety of... soft tissue treatment. Low power setting provides...
...RMES-Ready Amsco 3085 SP Surgical Table provides s...ence' capability. The table can now be networked w...uter Motion, Inc. and Stryker Endoscopy) to allow ...position. The surgeon uses either simple voice com...
Medicine Products: